![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | G01N 33/574 | (2006.01) |
G01N 33/574 | (2013.01) | ||
G01N 33/57415 | (2013.01) | ||
G01N 33/57446 | (2013.01) |
(11) | Number of the document | 3797296 |
(13) | Kind of document | T |
(96) | European patent application number | 19727597.7 |
Date of filing the European patent application | 2019-05-20 | |
(97) | Date of publication of the European application | 2021-03-31 |
(45) | Date of publication and mention of the grant of the patent | 2024-09-04 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2019/062972 |
Date | 2019-05-20 |
(87) | Number | WO 2019/224153 |
Date | 2019-11-28 |
(30) | Number | Date | Country code |
201862674566 P | 2018-05-21 | US |
(72) |
MURILLO, Adrian E. , US
NITTA, Hiro , US
MUNROE, Donald G. , US
LO, Amy A. , US
KUWATA, Takeshi , JP
KAITO, Akio , JP
OCHIAI, Atsushi , JP
|
(73) |
GENENTECH, INC. ,
1 DNA Way, South San Francisco, CA 94080,
US
Ventana Medical Systems, Inc. , 1910 E. Innovation Park Drive, Tucson, Arizona 85755, US National Cancer Center , 5-1-1, Tsukiji Chuo-ku, Tokyo 104-0045, JP |
(54) | HER2 HETEROGENEITY AS A BIOMARKER IN CANCER |
HER2 HETEROGENEITY AS A BIOMARKER IN CANCER |